Review article: Antibiotic-induced Clostridium difficile infection

被引:28
作者
Settle, CD
Wilcox, MH
机构
[1] UNIV LEEDS, DEPT MICROBIOL, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND
[2] GEN INFIRM, LEEDS LS1 3EX, W YORKSHIRE, ENGLAND
关键词
D O I
10.1046/j.1365-2036.1996.79251000.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The great majority of cases of Clostridium difficile infection are hospital-acquired, and the reported incidence in England and Wales has increased sixfold between 1990 and 1993, with at least 17 patients dying in a recent large nosocomial outbreak. C. difficile infection accounts for an average 3-week increased length of stay in hospital. Acquisition of a toxigenic strain of Clostridium difficile may be followed by asymptomatic carriage, diarrhoea, colitis or pseudomembranous colitis. Antibiotic treatment and older age are major risk factors for the development of symptomatic disease, but less well-defined differences in strain virulence and host susceptibility are also probably important, Accurate data on the relative risks of different antibiotics to induce symptomatic C. difficile infection are scarce, but third-generation cephalosporins are frequently implicated, New kits are becoming available for the laboratory diagnosis of C. difficile infection but many of these lack sensitivity, Oral metronidazole or vancomycin are the main treatment options but avoidance of further antibiotics should also be encouraged where possible, The role of environmental C. difficile spores, which are highly resistant to conventional disinfectants, needs to be defined. Proven strategies for the prevention of C. difficile infection are required, in particular protocols to ensure that cross-infection does not occur.
引用
收藏
页码:835 / 841
页数:7
相关论文
共 63 条
[21]   FACTORS INFLUENCING THE PHAGOCYTOSIS OF CLOSTRIDIUM-DIFFICILE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
DAILEY, DC ;
KAISER, A ;
SCHLOEMER, RH .
INFECTION AND IMMUNITY, 1987, 55 (07) :1541-1546
[22]   3RD-GENERATION CEPHALOSPORINS AS A RISK FACTOR FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DISEASE - A 4-YEAR SURVEY IN A GENERAL-HOSPITAL [J].
DELALLA, F ;
PRIVITERA, G ;
ORTISI, G ;
RIZZARDINI, G ;
SANTORO, D ;
PAGANO, A ;
RINALDI, E ;
SCARPELLINI, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (04) :623-631
[23]  
*DEP HLTH PUBL HLT, 1994, CLOSTR DIFF INF PREV
[24]   SEROGROUP-F STRAINS OF CLOSTRIDIUM-DIFFICILE PRODUCE TOXIN-B BUT NOT TOXIN-A [J].
DEPITRE, C ;
DELMEE, M ;
AVESANI, V ;
LHARIDON, R ;
ROELS, A ;
POPOFF, M ;
CORTHIER, G .
JOURNAL OF MEDICAL MICROBIOLOGY, 1993, 38 (06) :434-441
[25]   EPIDEMIOLOGY OF ANTIBIOTIC-ASSOCIATED COLITIS - ISOLATION OF CLOSTRIDIUM DIFFICLE FROM THE HOSPITAL ENVIRONMENT [J].
FEKETY, R ;
KIM, KH ;
BROWN, D ;
BATTS, DH ;
CUDMORE, M ;
SILVA, J .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (04) :906-908
[26]   TREATMENT OF ANTIBIOTIC-ASSOCIATED COLITIS WITH VANCOMYCIN [J].
FEKETY, R ;
SILVA, J ;
BUGGY, B ;
DEERY, HG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :97-102
[27]   TREATMENT OF ANTIBIOTIC-ASSOCIATED CLOSTRIDIUM-DIFFICILE COLITIS WITH ORAL VANCOMYCIN - COMPARISON OF 2 DOSAGE REGIMENS [J].
FEKETY, R ;
SILVA, J ;
KAUFFMAN, C ;
BUGGY, B ;
DEERY, HG .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (01) :15-19
[28]  
FEKETY R, 1994, PRINCIPLES PRACTICE, P978
[29]   CLOSTRIDIUM-DIFFICILE AND ITS CYTO-TOXIN IN FECES OF PATIENTS WITH ANTIMICROBIAL AGENT ASSOCIATED DIARRHEA AND MISCELLANEOUS CONDITIONS [J].
GEORGE, WL ;
ROLFE, RD ;
FINEGOLD, SM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (06) :1049-1053
[30]  
GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214